Erasmus Medical Center Pioneers Cardiovascular Care with Stereotaxis’s Genesis Robotic System

Erasmus University Medical Center (Erasmus MC) has advanced cardiovascular care and robotic electrophysiology by performing its first procedures using the Genesis Robotic Magnetic Navigation (RMN) System from Stereotaxis, Inc. (NYSE: STXS)

With this adoption, Erasmus MC becomes the first hospital in The Netherlands to implement the Genesis robotic system for arrhythmia treatment, strengthening its role as a global leader in robotic cardiac ablation and minimally invasive cardiovascular surgery. To date, the hospital has completed more than 4,500 robotic procedures using Stereotaxis platforms, making it one of Europe's top centers for robotic-guided electrophysiology

Advancing Arrhythmia Treatment with Robotic Cardiac Ablation

Cardiac arrhythmias, including atrial fibrillation and ventricular tachycardia, impact tens of millions worldwide, increasing the risk of stroke, heart failure, and sudden cardiac arrest. The Genesis robotic system introduces precision, speed, and safety to minimally invasive catheter ablation procedures.

Dr. Sing-Chien Yap, Director of Electrophysiology at Erasmus MC, noted:

"Genesis is fast and responsive. Combined with the MAGiC Catheter, we see significant improvements in treating arrhythmia patients, including children and those with congenital heart disease."

By combining robotic navigation, magnetic precision, and advanced catheter technology, the Genesis system reduces radiation exposure, shortens procedure times, and enhances outcomes for patients undergoing complex arrhythmia ablations.

Global Collaboration in Robotic Electrophysiology

Erasmus MC's partnership with Stereotaxis underscores the growing role of robotics in advancing interventional cardiology. David Fischel, Chairman and CEO of Stereotaxis, highlighted the long-standing collaboration:

"We appreciate our partnership with Erasmus and look forward to advancing technological progress, scientific discovery, and clinical care together."

Stereotaxis has pioneered surgical robotics for minimally invasive endovascular interventions, with its technologies used in over 150,000 patient treatments worldwide. The company continues to push innovation in robotic precision, safety, and connectivity in operating rooms across the U.S., Europe, and Asia.

Future of Robotic Cardiology and Electrophysiology

By deploying the Genesis Robotic Magnetic Navigation System, Erasmus MC is setting a precedent for robotic surgery in cardiology across Europe. The integration of robotics in cardiac electrophysiology labs ensures greater accuracy, minimally invasive care, and improved access for patients with difficult-to-treat heart rhythm disorders.

As the demand for robotic cardiac ablation, AI-driven electrophysiology, and advanced arrhythmia treatments grows, the Genesis platform is positioned to redefine the future of cardiovascular robotics and improve survival and quality of life for millions of patients.

Looking to enter a new market but unsure where to start? At BIS Research, we provide first-hand insights directly from key opinion leaders (KOLs), backed by rigorous primary and secondary research. Whether you're exploring opportunities in applications, regions or end users in surgical procedure volume database and robotics market, our segmentation-driven approach helps you tap into real market growth potential. Our strategic intelligence empowers you to make informed, confident decisions-from product positioning to pricing and regulatory planning.